Roche Boosted by Strong Drug Sales in US and China

by swisscham in Engineering, Manufacturing

The Swiss group on Thursday posted an 8% rise in third-quarter sales in local currencies – or 2.7% in Swiss francs, after adverse foreign exchange moves – helped by strong uptake of two new breast cancer drugs. The world’s largest maker of cancer drugs chalked up growth of 12% in the United States in the first nine months of the year and said it had seen continued strong growth in China, where sales were up 23%. This contrasts with the problems faced by other multinational drugmakers in China where an anti-bribery drive has hit promotional activities and sales. Many Chinese doctors have refused to see drug representatives for fear of being caught up in the widening scandal. The impact is expected to be felt most severely at GlaxoSmithKline, the company at the center of bribery allegations, which reports results on October 23. But Roche’s specialized cancer drugs, which are generally paid for privately in China, have escaped largely unscathed.

Leave a Reply

Your email address will not be published.

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>

Your Swiss Business Platform in China

SwissCham China has roughly 600 company members. Our Chamber maintains a strong relationship with the Embassy of Switzerland, Switzerland Global Enterprise, Swissnex and Switzerland Tourism. As the representative of the Swiss companies established in China, our goal is to help you to increase your business and visibility, especially amongst the Sino-Swiss business community.

Become A Member

Sign Up For Our Newsletter

  • This field is for validation purposes and should be left unchanged.
July 17, 2023
Published By in Business
July 16, 2023
Published By in Engineering / Manufacturing
July 13, 2023
Published By Consulate General of Switzerland in Guangzhou in Engineering / Manufacturing
July 3, 2023
Published By in Bilateral Relations